BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 11369822)

  • 1. Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension.
    Pestana M; Jardim H; Correia F; Vieira-Coelho MA; Soares-da-Silva P
    Nephrol Dial Transplant; 2001; 16 Suppl 1():53-9. PubMed ID: 11369822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
    Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
    Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerted action of dopamine on renal and intestinal Na(+)-K(+)-ATPase in the rat remnant kidney.
    Vieira-Coelho MA; Serrão P; Guimarães JT; Pestana M; Soares-da-Silva P
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1033-44. PubMed ID: 11097621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
    Pestana M; Vieira-Coelho MA; Pinto-do-O PC; Fernandes MH; Soares-da-Silva P
    Br J Pharmacol; 1995 Aug; 115(8):1349-58. PubMed ID: 8564191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal dopaminergic mechanisms in renal parenchymal diseases, hypertension, and heart failure.
    Soares-da-Silva P; Pestana M; Ferreira A; Damasceno A; Polónia J; Cerqueira-Gomes M
    Clin Exp Hypertens; 2000 Apr; 22(3):251-68. PubMed ID: 10803731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of renal dopaminergic system activity during the recovery of renal function in human kidney transplant recipients.
    Pestana M; Faria MS; Oliveira JG; Baldaia J; Santos A; Guerra LE; Soares-da-Silva P
    Nephrol Dial Transplant; 1997 Dec; 12(12):2667-72. PubMed ID: 9430869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
    Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
    Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High sodium intake increases the urinary excretion of L-3,4-dihydroxyphenylalanine but fails to alter the urinary excretion of dopamine and amine metabolites in Wistar rats.
    Vieira-Coelho MA; Pestana M; Soares-da-Silva P
    Gen Pharmacol; 1996 Dec; 27(8):1421-7. PubMed ID: 9304419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal dopamine and salt sensitivity of blood pressure in IgA nephropathy.
    Pestana M; Santos J; Santos A; Coroas A; Correia F; Serrão P; Valbuena C; Soares-da-Silva P
    Kidney Blood Press Res; 2004; 27(2):78-87. PubMed ID: 14718752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the renal dopaminergic system activity between Wistar rats from two suppliers.
    Sampaio-Maia B; Serrão P; Vieira-Coelho MA; Pestana M
    Acta Physiol Scand; 2003 May; 178(1):83-9. PubMed ID: 12713518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of renal dopaminergic-dependent natriuretic response to acute sodium load in black salt-sensitive subjects in contrast to salt-resistant subjects.
    Damasceno A; Santos A; Serrão P; Caupers P; Soares-da-Silva P; Polónia J
    J Hypertens; 1999 Dec; 17(12 Pt 2):1995-2001. PubMed ID: 10703901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats.
    Vieira-Coelho MA; Hussain T; Kansra V; Serrao MP; Guimaraes JT; Pestana M; Soares-Da-Silva P; Lokhandwala MF
    Hypertension; 1999 Oct; 34(4 Pt 1):666-72. PubMed ID: 10523344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: endogenous 5-hydroxytryptamine, 5-HT1A receptors and antinatriuresis during high sodium intake.
    Soares-da-Silva P; Vieira-Coelho MA; Pestana M
    Br J Pharmacol; 1996 Mar; 117(6):1193-8. PubMed ID: 8882615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of amino acid transporters in the rat remnant kidney.
    Amaral JS; Pinho MJ; Soares-da-Silva P
    Nephrol Dial Transplant; 2009 Jul; 24(7):2058-67. PubMed ID: 19155532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure, aging, and renal synthesis of dopamine.
    Ferreira A; Bettencourt P; Pestana M; Correia F; Serrão P; Martins L; Cerqueira-Gomes M; Soares-Da-Silva P
    Am J Kidney Dis; 2001 Sep; 38(3):502-9. PubMed ID: 11532681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure.
    Ferreira A; Bettencourt P; Pimenta J; Friões F; Pestana M; Soares-da-Silva P; Cerqueira-Gomes M
    Am Heart J; 2002 Mar; 143(3):391-7. PubMed ID: 11868042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of chronic inhibition of dopamine-metabolizing enzymes in the regulation of renal sodium and phosphate excretion in the rat remnant kidney.
    Sampaio-Maia B; Moreira-Rodrigues M; Pestana M
    Nephron Physiol; 2006; 103(1):p14-24. PubMed ID: 16352914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted renal dopaminergic system activity in HgCl2-induced membranous nephropathy.
    Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
    Life Sci; 2006 Feb; 78(11):1246-55. PubMed ID: 16182313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal dopaminergic system activity in uninephrectomized rats up to 26 weeks after surgery.
    Moreira-Rodrigues M; Sampaio-Maia B; Moura M; Pestana M
    Am J Nephrol; 2007; 27(3):232-9. PubMed ID: 17389783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.